Last 48 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
DaVita Inc.'s quarterly P/E stands at 11.6x, down 4.2% year-over-year.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 17.23 | 11.59 | 16.28 | 13.80 | 19.12 | 12.10 | 16.39 | 13.86 | 13.02 | 16.17 | 9.02 | 13.15 | 16.22 |
| — | -4.2% | -0.7% | -0.4% | +46.8% | -25.2% | +81.7% | +5.4% | -19.7% | -35.9% | -50.7% | +51.3% | -7.6% | |
| P/S Ratio | 0.77 | 0.69 | 0.72 | 0.82 | 0.96 | 0.95 | 1.08 | 0.97 | 1.02 | 0.77 | 0.71 | 0.78 | 0.65 |
| — | -27.4% | -33.5% | -15.7% | -5.3% | +23.2% | +51.3% | +23.6% | +55.9% | +31.3% | +8.8% | +17.1% | -35.3% | |
| P/B Ratio | 11.89 | 8.64 | 6.41 | 7.10 | 7.49 | 6.00 | 6.34 | 5.08 | 4.74 | 3.54 | 3.15 | 3.57 | 3.10 |
| — | +44.1% | +1.2% | +39.6% | +57.9% | +69.2% | +101.3% | +42.4% | +52.9% | +14.9% | -15.5% | -1.3% | -34.3% | |
| P/FCF | 7.97 | 6.33 | 3.63 | 13.55 | 84.57 | 8.32 | 5.24 | 4.57 | — | 7.41 | 4.24 | 7.21 | 5.96 |
| — | -23.9% | -30.7% | +196.5% | — | +12.2% | +23.6% | -36.6% | — | -35.3% | +24.4% | -83.1% | -58.3% | |
| EV / EBITDA | 9.08 | 8.23 | 8.77 | 8.11 | 9.88 | 8.05 | 8.72 | 8.64 | 8.94 | 8.74 | 7.15 | 8.72 | 9.54 |
| — | +2.3% | +0.5% | -6.1% | +10.5% | -7.9% | +22.0% | -0.8% | -6.3% | -14.6% | -25.3% | +6.2% | -14.9% | |
| EV / EBIT | 12.31 | 11.44 | 13.05 | 11.23 | 14.43 | 10.78 | 12.40 | 12.57 | 12.73 | 13.27 | 10.27 | 12.88 | 14.82 |
| — | +6.2% | +5.2% | -10.7% | +13.3% | -18.8% | +20.7% | -2.4% | -14.1% | -28.5% | -35.0% | +12.1% | -13.0% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
DaVita Inc.'s operating margin was 15.2% in Q4 2025, up 0.4 pp QoQ and down 1.9 pp YoY. Gross margin contracted 12.9% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 27.0% | 28.3% | 31.8% | 33.1% | 30.5% | 32.5% | 34.1% | 32.8% | 32.3% | 32.0% | 33.8% | 31.5% | 28.4% |
| — | -12.9% | -6.7% | +0.9% | -5.5% | +1.3% | +0.9% | +4.1% | +13.9% | +12.8% | +15.4% | +1.3% | -0.0% | |
| Operating Margin | 14.7% | 15.2% | 14.8% | 15.9% | 13.6% | 17.2% | 16.4% | 15.9% | 15.8% | 12.4% | 15.9% | 13.5% | 10.8% |
| — | -11.3% | -9.8% | +0.1% | -13.6% | +38.4% | +3.2% | +17.6% | +45.3% | +41.1% | +50.3% | -8.6% | -9.6% | |
| Net Margin | 5.5% | 6.5% | 4.4% | 5.9% | 5.1% | 7.9% | 6.6% | 7.0% | 7.8% | 4.8% | 7.9% | 6.0% | 4.0% |
| — | -17.8% | -33.2% | -15.6% | -35.2% | +64.3% | -16.7% | +17.3% | +94.0% | +105.1% | +121.1% | -22.5% | -30.1% |
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 46.0% | 17.4% | 9.8% | 12.4% | 8.7% | 12.0% | 9.2% | 8.8% | 8.9% | 5.4% | 9.0% | 7.1% | 5.0% |
| — | +44.9% | +5.6% | +41.0% | -2.5% | +122.3% | +2.2% | +24.3% | +79.0% | +70.8% | +81.7% | -28.0% | -26.6% | |
| ROA | 4.3% | 1.3% | 0.9% | 1.2% | 0.9% | 1.5% | 1.2% | 1.3% | 1.4% | 0.9% | 1.5% | 1.1% | 0.7% |
| — | -10.8% | -31.4% | -10.9% | -32.2% | +67.3% | -14.6% | +21.8% | +103.4% | +121.7% | +135.3% | -19.3% | -27.6% | |
| ROIC | 10.5% | 2.7% | 2.6% | 3.0% | 2.4% | 3.2% | 3.0% | 2.7% | 2.6% | 2.2% | 2.7% | 2.2% | 1.7% |
| — | -16.4% | -12.9% | +8.6% | -6.9% | +46.5% | +8.9% | +23.0% | +54.1% | +55.3% | +62.7% | -3.8% | -6.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
DaVita Inc.'s Debt/EBITDA ratio is 20.4x, down from 21.8x last quarter — elevated, raising questions about debt serviceability. Debt/Equity has risen for 10 consecutive quarters, indicating increasing financial leverage that investors should watch closely.
| Metric | TTM | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 12.99 | 12.99 | 9.74 | 8.25 | 7.42 | 5.77 | 5.50 | 4.82 | 4.49 | 4.05 | 3.94 | 4.36 | 4.76 |
| — | +125.2% | +77.2% | +71.4% | +65.2% | +42.4% | +39.5% | +10.3% | -5.6% | -23.7% | -32.1% | -23.1% | -3.6% | |
| Debt / EBITDA | 5.52 | 20.40 | 21.77 | 17.99 | 20.02 | 16.32 | 16.90 | 17.12 | 17.65 | 19.00 | 16.26 | 19.49 | 23.50 |
| — | +25.0% | +28.9% | +5.1% | +13.4% | -14.1% | +3.9% | -12.2% | -24.9% | -27.6% | -31.6% | -4.1% | +1.0% | |
| Current Ratio | 1.29 | 1.29 | 1.36 | 1.39 | 1.25 | 1.26 | 1.37 | 1.16 | 1.43 | 1.19 | 1.24 | 1.25 | 1.19 |
| — | +2.5% | -0.6% | +20.4% | -12.3% | +6.1% | +11.0% | -7.3% | +20.3% | -1.4% | -2.1% | -11.6% | -8.3% | |
| Quick Ratio | 1.24 | 1.24 | 1.32 | 1.34 | 1.20 | 1.21 | 1.33 | 1.12 | 1.37 | 1.13 | 1.19 | 1.20 | 1.14 |
| — | +2.1% | -0.8% | +20.5% | -12.4% | +7.2% | +11.3% | -7.3% | +19.8% | -2.5% | -2.3% | -11.9% | -8.4% | |
| Interest Coverage | 3.66 | 4.67 | 3.36 | 3.68 | 3.25 | 4.08 | 3.97 | 5.18 | 4.87 | 4.05 | 5.06 | 3.92 | 3.09 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 48 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonDaVita Inc.'s current P/E is 17.2x. The average P/E over the last 4 quarters is 15.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
DaVita Inc.'s current operating margin is 14.7%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking DaVita Inc.'s business trajectory between earnings reports.